Saamya Biotech (India) submits un-audited financial results

23 Feb 2019 Evaluate

Saamya Biotech (India) has informed about submission of Un-audited financial results for the Second quarter ending 30th September 2018 along with Limited Review Report. The Board Meeting Commenced at 4 PM and concluded at 5:15 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1513.30
Dr. Reddys Lab 5919.35
Cipla 1341.95
Zydus Lifesciences 928.05
Lupin 1570.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.